99
Alphamab
9966.HK·HKEXSuzhou CNFounded 2015600 employees
Small CapbiotechPublicOncology
Platform: PD-L1/CTLA-4
Market Cap
$0.5B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (9966.HK)
Loading 9966.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 996-4673 | 996-4673 | Phase 1/2 | 1 | APOC3 | PVNMOSD | ||
| 996-5071 | 996-5071 | Phase 1/2 | 1 | HER2 | Schizophrenia |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Alphamab trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)